NCT02710084View on ClinicalTrials.gov

Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 29, 2016

Primary Completion Date

July 29, 2020

Study Completion Date

July 29, 2020

Conditions
Phelan-McDermid Syndrome
Interventions
DRUG

Oxytocin

Intranasal oxytocin

DRUG

Saline

Placebo

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Alexander Kolevzon

OTHER

NCT02710084 - Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome | Biotech Hunter | Biotech Hunter